A translational perspective on the anti-anhedonic effect of ketamine and its neural underpinnings

© 2021. The Author(s)..

Anhedonia, a pronounced reduction in interest or pleasure in any of life's daily activities, is a cardinal symptom of major depression. In this Perspective article, we synthesise the recent evidence from rodent, monkey and human neuroimaging literature to highlight how the habenula, a small evolutionarily conserved subcortical structure located in the midbrain, may orchestrate the behavioural expression of anhedonia across fronto-mesolimbic networks. We then review how this circuitry can be modulated by ketamine, an NMDA receptor antagonist with rapid antidepressant properties. We propose that experimental paradigms founded in reinforcement learning and value-based decision-making can usefully probe this network and thereby help elucidate the mechanisms underlying ketamine's rapid antidepressant action.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:27

Enthalten in:

Molecular psychiatry - 27(2022), 1 vom: 22. Jan., Seite 81-87

Sprache:

Englisch

Beteiligte Personen:

Pulcu, Erdem [VerfasserIn]
Guinea, Calum [VerfasserIn]
Cowen, Philip J [VerfasserIn]
Murphy, Susannah E [VerfasserIn]
Harmer, Catherine J [VerfasserIn]

Links:

Volltext

Themen:

690G0D6V8H
Antidepressive Agents
Journal Article
Ketamine
Receptors, N-Methyl-D-Aspartate
Research Support, Non-U.S. Gov't
Review

Anmerkungen:

Date Completed 11.04.2022

Date Revised 05.02.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1038/s41380-021-01183-1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM327059559